Antisense antiviral compound and method for treating influenza viral infection

Details for Australian Patent Application No. 2005299306 (hide)

Owner AVI BioPharma, Inc. Massachusetts Institute of Technology

Inventors Iversen, Patrick L.; Ge, Qing; Chen, Jianzhu; Stein, David A.; Moulton, Hong

Agent Davies Collison Cave

Pub. Number AU-B-2005299306

PCT Pub. Number WO2006/047683

Priority 60/622,077 26.10.04 US; 11/259,434 25.10.05 US

Filing date 26 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 7 June 2012

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/047683 Priority application(s): WO2006/047683

7 June 2012 Application Accepted

  Published as AU-B-2005299306

20 September 2012 Alteration of Name

  The name of the applicant has been altered to Massachusetts Institute of Technology; Sarepta Therapeutics, Inc. 2006

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299310-Compositions and methods for short interfering nucleic acid inhibition of Nav1.8

2005299305-Brake controller with manually adjustable accelerometer